Search Within

GME, Medicine

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (228)
  2. Journal Article (177)
  3. Research Letter (10)
  4. Review (4)
  5. Correspondence (2)
  6. Editorial (2)
Groups
  1. Epidemiology and Biostatistics (423)
  2. Graduate Medical Education (423)
  3. Department of Medicine (399)
  4. Biostatistics Service (340)
  5. Hematology-Oncology Fellows (270)
  6. Hematologic Malignancies, Division of (256)

More Groups

People
  1. Gunjan Shah (95)
  2. Michael Scordo (94)
  3. Andriy Derkach (89)
  4. Sergio Giralt (85)
  5. Kylee Maclachlan (77)
  6. Alexander Lesokhin (71)

More People

Years
  1. 2025 (30)
  2. 2024 (105)
  3. 2023 (136)
  4. 2022 (95)
  5. 2021 (30)
  6. 2020 (17)

More Years

Publications
  1. Journal of Clinical Oncology (95)
  2. Blood (74)
  3. Clinical Lymphoma, Myeloma and Leukemia (27)
  4. Clinical Cancer Research (17)
  5. Annals of Oncology (12)
  6. Blood Advances (12)

More Publications

Publishers
  1. American Society of Clinical Oncology (102)
  2. American Society of Hematology (86)
  3. Elsevier Inc. (54)
  4. Nature Publishing Group (38)
  5. American Association for Cancer Research (32)
  6. Oxford University Press (24)

More Publishers

Results (423)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Intracranial outcomes with ipilimumab and nivolumab in melanoma brain metastases following progression on anti-PD-1 therapy
    Meeting Abstract

    Lochrin, S. E.; Kalvin, H. L.; Smithy, J. W.; Momtaz, P.; Shoushtari, A. N.; Panageas, K.; Postow, M. A.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Clinical outcomes of sacituzumab govitecan (SG) after prior exposure to enfortumab vedotin (EV) in patients with metastatic urothelial carcinoma (mUC)
    Meeting Abstract

    Sternschuss, M.; Toumbacaris, N.; Das, J. P.; Powles, T.; Bajorin, D. F.; Kotecha, R. R.; Laccetti, A. L.; Xiao, H.; Feld, E.; McHugh, D. J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Genomic biomarkers of CNS-specific outcomes in patients with breast cancer brain metastases
    Meeting Abstract

    Khatri, I. S.; Eichholz, J.; Boe, L. A.; Safonov, A.; Smith, D. R.; Ferraro, E.; Shen, J.; Imber, B. S.; Yu, Y.; Yamada, Y.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Correlation of peripheral blood monocytic myeloid-derived suppressor cells (M-MDSC) and T-cell receptor (TCR) dynamics with clinical outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) treated with nivolumab (NIVO)
    Meeting Abstract

    Gupta, A.; Whiting, K.; Keegan, N. M.; Schmalz, J.; Al-Ahmadie, H. A.; Regazzi, A. M.; McCoy, A. S.; Maher, C. A.; Iyer, G.; Rosenberg, J. E.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Patient satisfaction with cancer care delivery through telemedicine at a comprehensive cancer center across three years during and after the COVID-19 pandemic
    Meeting Abstract

    Doshi, S. D.; Khadem Charvadeh, Y.; Seier, K.; Bange, E. M.; Daly, R. M.; Polubriaginof, F. C. G.; Buckley, M. T.; Kuperman, G.; Stetson, P. D.; Schrag, D.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Germline pathogenic variants in a large convenience cohort of multiple melanoma subtypes
    Meeting Abstract

    Lochrin, S. E.; Kemel, Y.; Stuart, J.; Smithy, J. W.; Mandelker, D.; Momtaz, P.; Chatila, W. K.; Schultz, N.; Postow, M. A.; Stadler, Z. K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Sequential use of PI3K/AKT/mTOR pathway inhibitors alpelisib and everolimus in patients with hormone receptor-positive (HR+) metastatic breast cancer
    Meeting Abstract

    Shen, S.; Safonov, A.; Bromberg, M.; Chen, Y.; Ahmed, M.; Razavi, P.; Jhaveri, K. L.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Combined impact of primary tumor molecular profile and location in the relapse pattern of early-stage, microsatellite stable colorectal cancer
    Meeting Abstract

    Manca, P.; Kris, A.; Walch, H. S.; Fong, C.; Jee, J.; Pichotta, K.; Schultz, N.; Chatila, W. K.; Sanchez-Vega, F.; Yaeger, R.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Do patients with myxofibrosarcoma and undifferentiated pleomorphic sarcoma have different clinical outcomes to immune checkpoint blockade-based therapy?
    Meeting Abstract

    Rosenbaum, E.; Seier, K.; Bradic, M.; Desir, R.; Kelly, C. M.; Movva, S.; Avutu, V.; Banks, L. B.; Chan, J. E.; Chi, P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Real-world schedule de-escalation of teclistamab in patients with relapsed/refractory multiple myeloma
    Meeting Abstract

    Tan, C. R. C.; Derkach, A.; Maclachlan, K.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Rajeeve, S.; Shah, G. L.; Scordo, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save